Markus Lenz

Dr. Markus Lenz

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2011
Verified
Closed access
LWLenny Winkel
Lenny Winkel
CJC. Annette Johnson
C. Annette Johnson
MLMarkus Lenz
Markus Lenz
TGTim Grundl
Tim Grundl
OLOlivier X. Leupin
Olivier X. Leupin
LCLaurent Charlet
Laurent Charlet

1 June 2009 in Science of The Total Environment
Verified
Journal Article
Closed access
MLMarkus Lenz
Markus Lenz
PLPiet Nicolaas Luc Lens
Piet Nicolaas Luc Lens

1 January 2019 in Journal of Hazardous Materials
Verified
Journal Article
Open access
AIArda Isildar
Arda Isildar
Eric D. van HullebuschEric D. van Hullebusch
Eric D. van Hullebusch
MLMarkus Lenz
Markus Lenz
GLGijs Du Laing
Gijs Du Laing
AMAlessandra Marra
Alessandra Marra
KKKerstin Kuchta
Kerstin Kuchta
Critical raw materials (CRMs) are essential in the development of novel high-tech applications. They are essential in sustainable materials and green technologies, including renewable energy, emissionfree electric vehicles and energy-efficient lighting. However, the sustainable supply of CRMs is a major concern. Recycling end-of-life devices is an integral element of the CRMs supply policy of many countries. Waste electrical and electronic equipment (WEEE) is an important secondary source of CRMs. Currently, pyrometallurgical processes are used to recycle metals from WEEE. These processes are deemed imperfect, energy-intensive and non-selective towards CRMs. Biotechnologies are a promising alternative to the current industrial best available technologies (BAT). In this review, we present the current frontiers in CRMs recovery from WEEE using biotechnology, the biochemical fundamentals of these bio-based technologies and discuss recent research and development (R&D) activities. These technologies encompass biologically induced leaching (bioleaching) from various matrices,biomass-induced sorption (biosorption), and bioelectrochemical systems (BES).

19 January 2022 in Cell
Verified
Journal Article
Closed access
JLJonas Lötscher
Jonas Lötscher
ALAdrià-Arnau Martí i Líndez
Adrià-Arnau Martí i Líndez
NKNicole Kirchhammer
Nicole Kirchhammer
ECElisabetta Cribioli
Elisabetta Cribioli
GAGreta Maria Paola Giordano Attianese
Greta Maria Paola Giordano Attianese
CHChristoph Hess
Christoph Hess

1 April 2014 in Science of The Total Environment
Verified
Journal Article
Closed access
NBNadja Rebecca Brun
Nadja Rebecca Brun
MLMarkus Lenz
Markus Lenz
BWBernhard Wehrli
Bernhard Wehrli
KFKarl Fent
Karl Fent

15 September 2013 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
PDF file
BRBenjamin Ricken
Benjamin Ricken
PCPhilippe F. X. Corvini
Philippe F. X. Corvini
DCDanuta Cichocka
Danuta Cichocka
MPMartina Parisi
Martina Parisi
MLMarkus Lenz
Markus Lenz
BKBoris A. Kolvenbach
Boris A. Kolvenbach
Sulfonamide antibiotics have a wide application range in human and veterinary medicine. Because they tend to persist in the environment, they pose potential problems with regard to the propagation of antibiotic resistance. Here, we identified metabolites formed during the degradation of sulfamethoxazole and other sulfonamides in Microbacterium sp. strain BR1. Our experiments showed that the degradation proceeded along an unusual pathway initiated by ipso -hydroxylation with subsequent fragmentation of the parent compound. The NADH-dependent hydroxylation of the carbon atom attached to the sulfonyl group resulted in the release of sulfite, 3-amino-5-methylisoxazole, and benzoquinone-imine. The latter was concomitantly transformed to 4-aminophenol. Sulfadiazine, sulfamethizole, sulfamethazine, sulfadimethoxine, 4-amino- N -phenylbenzenesulfonamide, and N -(4-aminophenyl)sulfonylcarbamic acid methyl ester (asulam) were transformed accordingly. Therefore, ipso -hydroxylation with subsequent fragmentation must be considered the underlying mechanism; this could also occur in the same or in a similar way in other studies, where biotransformation of sulfonamides bearing an amino group in the para -position to the sulfonyl substituent was observed to yield products corresponding to the stable metabolites observed by us.